Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • Oral bisphosphonate use and al...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
Oral bisphosphonate use and all‐cause mortality in patients with advanced (stage IIIB+) chronic kidney disease: a propensity score analysis

Oral bisphosphonate use and all‐cause mortality in patients with advanced (stage IIIB+) chronic kidney disease: a propensity score analysis

Bibliographic Details
Main Authors: Alarkawi, D, Bliuc, D, Pallares, N, Tebe, C, Cooper, C, Caskey, F, Ben-Shlomo, Y, Judge, A, Javaid, K, Diez-Perez, A, Center, J, Prieto-Alhambra, D
Format: Conference item
Published: Wiley 2018
  • Holdings
  • Description
  • Similar Items
  • Staff View

Similar Items

  • Oral bisphosphonate use and all-cause mortality in patients with advanced (stage IIIB plus ) chronic kidney disease: a population-based cohort study
    by: Alarkawi, D, et al.
    Published: (2017)
  • Oral bisphosphonates and chronic kidney disease: progression and safety
    by: Prieto-Alhambra, D, et al.
    Published: (2018)
  • The effect of oral bisphosphonates on acute kidney injury, gastrointestinal events and hypocalcaemia in patients with chronic kidney disease
    by: Robinson, D, et al.
    Published: (2018)
  • The effect of oral bisphosphonates on acute kidney injury, gastrointestinal events and hypocalcaemia in patients with chronic kidney disease
    by: Ali, M, et al.
    Published: (2018)
  • Bisphosphonates to reduce bone fractures in stage 3B+ chronic kidney disease: a propensity score-matched cohort study
    by: Robinson, DE, et al.
    Published: (2021)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs